• ホーム
  • 検索結果
  • A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission.

A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission.

Autophagy (2015-06-27)
Jing Zhou, Guobing Li, Yi Zheng, Han-Ming Shen, Xiaoye Hu, Qian-Liang Ming, Cheng Huang, Peng Li, Ning Gao
要旨

Autophagy inhibition has been widely accepted as a promising therapeutic strategy in cancer, while the lack of effective and specific autophagy inhibitors hinders its application. Here we found that liensinine, a major isoquinoline alkaloid, inhibits late-stage autophagy/mitophagy through blocking autophagosome-lysosome fusion. This effect is likely achieved via inhibiting the recruitment of RAB7A to lysosomes but not to autophagosomes. We further investigated the effects of autophagy inhibition by liensinine on the therapeutic efficacy of chemotherapeutic drugs and found that cotreatment of liensinine markedly decreased the viability and increased apoptosis in breast cancer cells treated with various chemotherapeutic agents. Mechanistically, we found that inhibition of autophagy/mitophagy by liensinine enhanced doxorubicin-mediated apoptosis by triggering mitochondrial fission, which resulted from dephosphorylation and mitochondrial translocation of DNM1L. However, blocking autophagosome/mitophagosome formation by pharmacological or genetic approaches markedly attenuated mitochondrial fission and apoptosis in cells with combinatatorial treatment. Moreover, liensinine was synergized with doxorubicin to inhibit tumor growth in MDA-MB-231 xenograft in vivo. Our findings suggest that liensinine could potentially be further developed as a novel autophagy/mitophagy inhibitor, and a combination of liensinine with classical chemotherapeutic drugs could represent a novel therapeutic strategy for treatment of breast cancer.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
HEPES, ≥99.5% (titration)
Sigma-Aldrich
スクロース, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
塩化ナトリウム, BioXtra, ≥99.5% (AT)
Sigma-Aldrich
HEPES, BioPerformance Certified, ≥99.5% (titration), suitable for cell culture
Sigma-Aldrich
塩化マグネシウム, anhydrous, ≥98%
Sigma-Aldrich
塩化マグネシウム 溶液, for molecular biology, 1.00 M±0.01 M
Sigma-Aldrich
塩化ナトリウム, for molecular biology, DNase, RNase, and protease, none detected, ≥99% (titration)
Sigma-Aldrich
チアゾリルブルーテトラゾリウムブロミド, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥97.5% (HPLC)
Sigma-Aldrich
スクロース, ≥99.5% (GC)
Sigma-Aldrich
エチレンジアミン四酢酸, ACS reagent, 99.4-100.6%, powder
Sigma-Aldrich
スクロース, BioXtra, ≥99.5% (GC)
Sigma-Aldrich
チアゾリルブルーテトラゾリウムブロミド, 98%
Sigma-Aldrich
フェニルメチルスルホニルフルオリド, ≥98.5% (GC)
Sigma-Aldrich
ECMゲル EHS肉腫由来, liquid, BioReagent, suitable for cell culture
Sigma-Aldrich
DL-ジチオトレイトール 溶液, BioUltra, for molecular biology, ~1 M in H2O
Sigma-Aldrich
ピルビン酸ナトリウム, ReagentPlus®, ≥99%
Sigma-Aldrich
塩化ナトリウム, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
Sigma-Aldrich
塩化ナトリウム 溶液, 0.9% in water, BioXtra, suitable for cell culture
Sigma-Aldrich
MES, low moisture content, ≥99% (titration)
Sigma-Aldrich
塩化ナトリウム 溶液, 5 M in H2O, BioReagent, for molecular biology, suitable for cell culture
Sigma-Aldrich
スクロース, BioUltra, for molecular biology, ≥99.5% (HPLC)
Sigma-Aldrich
エチレンジアミン四酢酸, anhydrous, BioUltra, ≥99% (titration)
Supelco
DL-ジチオトレイトール 溶液, 1 M in H2O
Sigma-Aldrich
エチレングリコール-ビス(2-アミノエチルエーテル)-N,N,N′,N′-四酢酸, for molecular biology, ≥97.0%
Sigma-Aldrich
L-グルタミン, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
ピューロマイシン 二塩酸塩, Ready Made Solution, from Streptomyces alboniger, 10 mg/mL in H2O
Sigma-Aldrich
HEPES緩衝液, 1 M in H2O
Sigma-Aldrich
クロロキン 二リン酸塩, powder or crystals, 98.5-101.0% (EP)
Sigma-Aldrich
塩化ナトリウム 溶液, 5 M
Sigma-Aldrich
スクロース, puriss., meets analytical specification of Ph. Eur., BP, NF